N-Ethyl-N''-(5-nitro-2-thiazolyl)urea maintains therapeutic activity towards treatment of Salmonella typhimurium and B. fragilis infections due to the nitrothiazole moiety within the substructure.
N-Ethyl-N'-(5-nitro-2-thiazolyl)urea maintains therapeutic activity towards treatment of Salmonella typhimurium and B. fragilis infections due to the nitrothiazole moiety within the substructure.
ChEBI: Nithiazide is a C-nitro compound and a member of 1,3-thiazoles.
Crystals or brown powder.
ACUTE/CHRONIC HAZARDS: When heated to decomposition 1-ethyl-3-(5-nitrothiazol-2-yl)urea emits toxic fumes.
Flash point data for 1-ethyl-3-(5-nitrothiazol-2-yl)urea are not available; however, 1-ethyl-3-(5-nitrothiazol-2-yl)urea is probably combustible.
Suspected carcinogen
with experimental carcinogenic data.
Moderately toxic by ingestion. Mutation data
reported. When heated to decomposition it
emits very toxic fumes of NOx and POx.
